Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

Talaris Therapeutics, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 425 Form 425 - Prospectuses and communications, business combinations:
10/10/2023 8-K/A Quarterly results
10/06/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Talaris Therapeutics Declares Special Dividend In Connection with Proposed Merger with Tourmaline Bio"
10/06/2023 425 Form 425 - Prospectuses and communications, business combinations:
10/06/2023 8-K Other Events  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
08/25/2023 S-4/A Form S-4/A - Registration of securities, business combinations: [Amend]
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/19/2023 S-4 Form S-4 - Registration of securities, business combinations:
07/06/2023 4 Fenton Mary Kay (CFO) has filed a Form 4 on Talaris Therapeutics, Inc.
Txns: Paid exercise price by delivering 12,946 shares @ $3.08, valued at $39.9k
07/06/2023 4 Requadt Scott (Former Chief Executive Officer) has filed a Form 4 on Talaris Therapeutics, Inc.
Txns: Paid exercise price by delivering 11,786 shares @ $3.08, valued at $36.3k
07/06/2023 SC 13G RA CAPITAL MANAGEMENT, L.P. reports a 5.5% stake in TALARIS THERAPEUTICS, INC.
07/05/2023 144 Form 144 - Report of proposed sale of securities:
07/05/2023 144 Form 144 - Report of proposed sale of securities:
06/09/2023 4 Ildstad Suzanne (Director) has filed a Form 4 on Talaris Therapeutics, Inc.
Txns: Sold 75,001 shares @ $2.3879, valued at $179.1k
Sold 40,642 shares @ $2.4795, valued at $100.8k
Sold 25,419 shares @ $2.4642, valued at $62.6k
06/07/2023 4 Ildstad Suzanne (Director) has filed a Form 4 on Talaris Therapeutics, Inc.
Txns: Sold 7,841 shares @ $2.5194, valued at $19.8k
Sold 25,549 shares @ $2.5283, valued at $64.6k
06/01/2023 144 Form 144 - Report of proposed sale of securities:
05/30/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Investor Contact"
04/28/2023 ARS Form ARS - Annual Report to Security Holders:
04/27/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
04/27/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
04/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/21/2023 144 Form 144 - Report of proposed sale of securities:
04/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/14/2023 8-K Quarterly results
03/31/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/31/2023 10-K Annual Report for the period ended December 31, 2022
03/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/10/2023 8-K Regulation FD Disclosure  Interactive Data
03/02/2023 4 Ildstad Suzanne (Director) has filed a Form 4 on Talaris Therapeutics, Inc.
Txns: Sold 29 shares @ $2.05, valued at $59.5
02/23/2023 4 Ildstad Suzanne (Director) has filed a Form 4 on Talaris Therapeutics, Inc.
Txns: Sold 3,500 shares @ $2.0529, valued at $7.2k
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy